Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.86
+0.42 (+0.33%)
Streaming Delayed Price
Updated: 3:34 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
69
70
Next >
Merck Swings Into Q2 Loss On Prometheus Biosciences Acquisition Charge, But Raises FY23 Revenue Outlook
August 01, 2023
Merck & Co Inc's (NYSE: MRK) Q2 sales reached $15.04 billion, up 3% Y/Y, beating the consensus of $14.39 billion.
Via
Benzinga
Nasdaq, S&P 500 Futures Pullback After Strong July; Why This Analyst Recommends Staying Fully Invested
August 01, 2023
Via
Benzinga
Merck Outplays The Covid Decline, But Prometheus Buyout Weighs On Profits
August 01, 2023
Merck beat sales expectations on Tuesday, though reported losses due to its Prometheus takeover.
Via
Investor's Business Daily
Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda
July 31, 2023
Pharmaceutical company Merck & Company (NYSE: MRK) reports second quarter financial results before market open Tuesday.
Via
Benzinga
Earnings Extravaganza: Another One-Third Of S&P 500 Companies Report This Week, Including Amazon, Apple
July 31, 2023
(Monday market open) It’s “tech week” on Wall Street. No, wait, it’s “pharma week.” Or is it “employment week?” How about all three?
Via
Benzinga
Merck & Co's Earnings Outlook
July 31, 2023
Via
Benzinga
Check Out What Whales Are Doing With MRK
July 20, 2023
Via
Benzinga
Merck & Co Unusual Options Activity
July 17, 2023
Via
Benzinga
3 Pharma Stocks to Buy for Their Promising Progress
July 31, 2023
Explore the top promising pharma stocks, leading the proverbial marathon towards transformative healthcare.
Via
InvestorPlace
7 Dow Stocks to Buy as Recession Fears Roll Back
July 30, 2023
These Dow stocks to buy are stable and look stronger as soft landing perspectives look more and more possible this year.
Via
InvestorPlace
The Dow Breaks 13-Day Winning Streak, Fed Raises Interest Rates To 2001 Levels And AI Is The Buzzword For Big Tech Earnings: The Week In The Markets
July 28, 2023
Via
Benzinga
Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations
July 28, 2023
Cancer drug manufacturers, including Johnson & Johnson (NYSE: JNJ), anticipate that injectable versions of some popular treatments will not be included in U.S.
Via
Benzinga
Merck Releases Encouraging Data From Two Late-Stage Studies For Pneumococcal Conjugate Vaccine
July 27, 2023
Merck & Co Inc (NYSE: MRK) announced topline results from two Phase 3 trials evaluating V116, the company's investigational 21-valent pneumococcal conjugate vaccine in vaccine-naïve
Via
Benzinga
Jim Cramer Recommends Holding This Health Care Stock: 'Re-Inventing Itself, Doing A Terrific Job'
July 27, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Tri Pointe Homes, Inc. (NYSE: TPH) is "still good.
Via
Benzinga
Individualized Cancer Treatment: Merck/Moderna's Personalized Skin Cancer Therapy Enters Late-Stage Of Development
July 26, 2023
Merck & Co Inc (NYSE: MRK) and Moderna Inc (NASDAQ: MRNA) initiated a pivotal Phase 3 randomized V940-001 trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy (INT),...
Via
Benzinga
Moderna On Cathie Wood's Radar Ahead Of Q2 Results: Ark Boosts Stake In COVID-19 Vaccine Maker By $12M This Week
July 26, 2023
Cathie Wood's Ark Invest bought over $12 million worth of Moderna shares as the biopharma expands its pipeline beyond COVID-19.
Via
Benzinga
Russia Is Seizing European Company Assets — What US Businesses Are Still At Risk?
July 24, 2023
Via
Benzinga
Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data
July 24, 2023
HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX)
Via
Benzinga
Moderna Is Fairly Valued, Balancing Declining COVID-19 Base Business with Promising Future Pipeline: Analyst
July 24, 2023
William Blair initiated coverage on Moderna Inc (NASDAQ: MRNA) with a Market Perform rati
Via
Benzinga
Top 5 Momentum Stocks For Higher Profits In 2023
July 22, 2023
Whether you’re a seasoned investor seeking new avenues for growth or a fresh face in trading, these momentum stocks are worth considering on your journey toward financial success and capitalizing on...
Via
Talk Markets
Dow Jones Hits Milestone: 10th Straight Day In Green, Longest Winning Streak Since Early 2017
July 21, 2023
Via
Benzinga
Drug Pricing Negotiation Program: Johnson & Johnson Joins Legal Battle Against US Government
July 19, 2023
Johnson & Johnson (NYSE: JNJ) has reportedly taken legal action against the U.S.
Via
Benzinga
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 18, 2023
Read the latest report on NanoViricides here.
Via
Benzinga
3 Biotech Stocks for Getting Rich in 2023
July 18, 2023
These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist.
Via
InvestorPlace
7 Safe Stocks to Buy as Fed Gears Up for Disinflation
July 18, 2023
With a hawkish monetary policy the possible outcome of the Federal Reserve impact, these are the safe stocks to buy right now.
Via
InvestorPlace
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
July 17, 2023
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for...
Via
Benzinga
Why Are Dow Stocks Up Today?
July 14, 2023
The Dow closed in the green today despite some slight weakness in both the S&P 500 and Nasdaq Composite. Why are Dow stocks up today?
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
July 14, 2023
Via
Benzinga
Roivant Surges As Roche Reportedly Considers $7 Billion Drug Takeover
July 14, 2023
The report sent Roivant Sciences higher Friday, but a deal is far from guaranteed.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
July 14, 2023
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.